BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >

Worldwide Interpol operation Pangea XIV leads to shutdowns and arrests

Operation Pangea is a yearly recurring operation in which Interpol aims to remove the online sale of counterfeit and/or illicit medicines and medical devices. Furthermore, the operation aims to make the public aware of the the risks associated with buying medicines and medical devices online from unregulated websites. During the Pangea XIV operation, which took place between 18 and 25 May 2021, thousands of illicit online pharmacies were taken offline, numerous medical devices and medication have been seized by local customs and arrests were made.

Having counterfeit and illicit medication and medical devices on the market is dangerous for multiple reasons. In case of counterfeit or illicit medication the quality and composition of the medicine cannot be guaranteed. It is possible that this medication contains no active ingredients, the wrong amount of active ingredients, dangerous ingredients or the products have a modified expiration date. In case of counterfeit or illicit medical devices the quality of the medical device cannot be guaranteed, and the medical device can be malfunctioning or carry out malicious acts.

The police, customs and health regulatory authorities from 92 countries worked together with Interpol to make this 14th operation a success. This year, Interpol stated that 113,020 links of online marketplaces around the world were shut down. The Swiss authorities released the information that worldwide a total of 9 million units of illegal and counterfeit medicinal products were seized. As part of Pangea is to raise awareness amongst the public, the countries involved also organized social media campaigns.

In 2020 as well as 2021, a rise in fake medication and medical devices was noticed related to the Covid-19 crisis, such as facemasks, hand sanitizers and antiviral medication. It seems that i.a. illicit online pharmacies around the world are using the Covid-19 crisis to their benefit. More than half of all medical devices that were seized during this years operation were fake Covid-19 tests, which on its own already lead to 277 arrests and the seizing of goods with a worth of more than 23 million dollars.

Links:

Pharmaceutical crime operations (interpol.int)

Operation PANGEA XIV: campaign against counterfeit and illegally imported medicinal products (admin.ch)

 

Written by
Alexandra Michel
Alexandra Michel
As an associate in our Intellectual Property Group in Amsterdam, I specialise mainly in patent disputes and trade secrets. Within Bird & Bird's Intellectual Property Group, I advise and litigate on all areas of Intellectual Property and mainly focus on patent disputes and trade secrets. Next to this, I am particularly interested in the life sciences and healthcare industry. Working on complex and interesting legal intellectual property issues gives me energy. What motivates me is to offer clients the best advice and tailor-made solutions to complex legal matters while not losing sight of the interests of the client. Before joining Bird & Bird, I worked at another international law firm and interned at multiple international and niche law firms as well as the Embassy of the Netherlands in Paris. I am a member of the International Association for the Protection of Intellectual Property (AIPPI) and the Association of Young Litigators (VJP).
Hester Borger
Hester Borger
As an associate in our Intellectual Property Group in The Hague, I specialise in IP law and bring my passion for technology to the fore when I'm advising our clients on their IP matters. My experience includes dispute resolution and regulatory advice. As a member of Bird & Bird's Life Sciences and Healthcare Group, I work daily on complex cross-country cases together with our other offices. In this way, we can guarantee solid advice regarding the complex challenges our clients are facing and ensure the best possible strategies and tactics in a sector that is ever-changing. The international structure of Bird & Bird is an important asset. Working together with my international colleagues and our clients is, to me, the only way to set out solid litigation and regulatory strategies in the complex field of life sciences and biotechnology. I also highly enjoy working in this international environment. I am a member of the International Association for the Protection of Intellectual Property (AIPPI) and Female Intellectual Property Experts (FIPE).

Related articles

Are German Courts the “Spoilsport” of the “Divisional Game” when it comes to Preliminary Injunction Requests?
If a patentee undertakes actions with respect to a patent of the same patent family (e.g. waiving the...
COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry
COVID-19 presents an unprecedented challenge to the global life sciences industry.  Members...
UK Supreme Court hearing appeal over permitted breadth of patent claims
Yesterday and today the Supreme Court has been hearing an appeal concerning Regeneron's...
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.